Generic Parkinson's drug shows promise in healthy volunteer study
NCT ID NCT07519278
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new generic version of pramipexole extended-release tablets works the same as the brand-name drug (MIRAPEX ER) in 49 healthy Chinese adults. Participants took a single dose of either the generic or brand-name drug, and researchers measured drug levels in their blood to check for bioequivalence. The study also monitored for side effects. This is a Phase 1 trial, meaning it focused on safety and how the body processes the drug, not on treating a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The General Hospital of Western Theater Command PLA
Chengdu, Sichuan, China